Sorin is now LivaNova. Learn more here

Oct 09, 2015

SORIN AND CYBERONICS ANNOUNCE APPOINTMENT OF REMAINING POST-MERGER DIRECTORS OF COMBINED COMPANY

Milan, Italy and Houston, TX, October 9, 2015 – Sorin S.p.A. (MTA; Reuters Code: SORN.MI) (“Sorin”), a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. (NASDAQ: CYBX, “Cyberonics”), a medical device company with core expertise in neuromodulation, today announced the two remaining designees to the Board of Directors of the combined company, LivaNova PLC (“LivaNova”), effective at the close of their proposed merger.

click here to view the release

Latest News

Version unknown | Revision 99192 | Status unstable | SessionId D7BE0997389BF756E4E95C83665DC275.jvm0